Please use this identifier to cite or link to this item: http://dspace.sctimst.ac.in/jspui/handle/123456789/10838
Title: Cyclometalated Ir(III) complex as lysosome targeted photodynamic therapeutic agent for integrated imaging and therapy in cancer cells.
Authors: Sudheesh, KV
Jayaram, PS
Samanta, A
Kochan, S
Bejoymohandas, KS
Jayasree, RS
Ajayaghosh, A
Issue Date: Jun-2018
Publisher: Chemistry - A European Journal
Citation: Sudheesh KV, Jayaram PS, Samanta A, Kochan S. Bejoymohandas KS, Jayasree RS, and Ajayaghosh A. Cyclometalated Ir(III) complex as lysosome targeted photodynamic therapeutic agent for integrated imaging and therapy in cancer cells. Chemistry - A European Journal. 2018
Abstract: Organelle targeted photosensitizers (PSs) having luminescence properties are potential theranostic agents for simultaneous luminescence imaging and photodynamic therapy. Herein, we report a water soluble luminescent cyclometalated Ir(III) complex, Ir-Bp-Ly as lysosome targeted theranostic probe. Ir-Bp-Ly exhibits exceptional photophysical properties of good triplet state quantum yield (0.90), singlet oxygen generation quantum yield (0.71 at pH 4) and long lifetime (1.47 µs). Interestingly, Ir-Bp-Ly localized mostly in the lysosome because of the presence of morpholine units, suggesting its potential as a lyso-tracker. Ir-Bp-Ly displayed notable PDT effect in C6 glioma cells, as these PS efficiently generated ROS owing to the close proximity energy levels between triplet energy states of Ir-Bp-Ly and molecular oxygen (3O2). The mechanism of cell death was studied through caspase-3/7 and flow cytometry analysis that clearly established the apoptotic pathway.
URI: : http://dx.doi.org/10.1002/chem.201801918
http://dspace.sctimst.ac.in/jspui/handle/123456789/10838
Appears in Collections:Journal Articles

Files in This Item:
File Description SizeFormat 
2018_6_2.pdf1.77 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.